Published in Arch Ophthalmol on August 01, 2002
Ocular drug delivery. AAPS J (2010) 2.19
Bovine and porcine transscleral solute transport: influence of lipophilicity and the Choroid-Bruch's layer. Invest Ophthalmol Vis Sci (2006) 1.18
Retracted Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models. Invest Ophthalmol Vis Sci (2011) 1.00
Characterization of the biological effect of fish fibrin glue in experiments on rats: immunological and coagulation studies. J Biomed Mater Res A (2010) 0.79
Severe aseptic orbital cellulitis with subtenon carboplatin for intraocular retinoblastoma. Indian J Ophthalmol (2010) 0.78
Carboplatin loaded polymethylmethacrylate nano-particles in an adjunctive role in retinoblastoma: an animal trial. Indian J Ophthalmol (2014) 0.75
Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology (2012) 4.61
Retinal pigment epithelial changes after macular hole surgery with indocyanine green-assisted internal limiting membrane peeling. Am J Ophthalmol (2002) 2.20
Interface fluid syndrome in human eye bank corneas after LASIK: causes and pathogenesis. Ophthalmology (2007) 1.89
Neovascular membranes associated with idiopathic juxtafoveolar telangiectasis. Arch Ophthalmol (2002) 1.81
Increased endothelial cell density in the paracentral and peripheral regions of the human cornea. Am J Ophthalmol (2003) 1.79
Clinicopathologic findings in choroidal melanomas after failed transpupillary thermotherapy. Am J Ophthalmol (2003) 1.69
Review of corneal endothelial specular microscopy for FDA clinical trials of refractive procedures, surgical devices, and new intraocular drugs and solutions. Cornea (2008) 1.68
Ocular drug delivery. Expert Opin Drug Deliv (2006) 1.61
Depth-dependent cohesive tensile strength in human donor corneas: implications for refractive surgery. J Refract Surg (2008) 1.58
Toxic anterior segment syndrome. J Cataract Refract Surg (2006) 1.53
Mechanisms of corneal tissue cross-linking in response to treatment with topical riboflavin and long-wavelength ultraviolet radiation (UVA). Invest Ophthalmol Vis Sci (2009) 1.41
Evaluation of endothelial mucin layer thickness after phacoemulsification with next generation ophthalmic irrigating solution. Cornea (2008) 1.39
Cohesive tensile strength of human LASIK wounds with histologic, ultrastructural, and clinical correlations. J Refract Surg (2005) 1.33
Clinical outcome of confluent laser photoablation for retinopathy of prematurity. J AAPOS (2002) 1.32
Corneal ectasia after excimer laser keratorefractive surgery: histopathology, ultrastructure, and pathophysiology. Ophthalmology (2008) 1.22
Suprachoroidal drug delivery to the back of the eye using hollow microneedles. Pharm Res (2010) 1.20
Histologic, ultrastructural, and immunofluorescent evaluation of human laser-assisted in situ keratomileusis corneal wounds. Arch Ophthalmol (2005) 1.18
Biomechanical and wound healing characteristics of corneas after excimer laser keratorefractive surgery: is there a difference between advanced surface ablation and sub-Bowman's keratomileusis? J Refract Surg (2008) 1.17
Subconjunctival carboplatin in fibrin sealant in the treatment of transgenic murine retinoblastoma. Ophthalmology (2005) 1.16
Effect of circulation on the disposition and ocular tissue distribution of 20 nm nanoparticles after periocular administration. Mol Vis (2008) 1.15
Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol Vis (2005) 1.12
Ischemic necrosis and atrophy of the optic nerve after periocular carboplatin injection for intraocular retinoblastoma. Am J Ophthalmol (2006) 1.12
Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis (2007) 1.10
Long-term histopathologic findings in human corneal wounds after refractive surgical procedures. Am J Ophthalmol (2005) 1.08
Targeted administration into the suprachoroidal space using a microneedle for drug delivery to the posterior segment of the eye. Invest Ophthalmol Vis Sci (2012) 1.07
Intrascleral drug delivery to the eye using hollow microneedles. Pharm Res (2008) 1.07
Antibody blockade of junctional adhesion molecule-A in rabbit corneal endothelial tight junctions produces corneal swelling. Invest Ophthalmol Vis Sci (2006) 1.06
Multistate outbreak of toxic anterior segment syndrome, 2005. J Cataract Refract Surg (2008) 1.06
Three cases of large retinal capillary hemangiomas treated with verteporfin and photodynamic therapy. Arch Ophthalmol (2005) 1.06
Enzymatic detergents and toxic anterior segment syndrome. Ophthalmology (2013) 1.05
Retinal function after subconjunctival injection of carboplatin in fibrin sealant. Retina (2004) 1.05
Pharmacokinetics of intraocular drug delivery by periocular injections using ocular fluorophotometry. Invest Ophthalmol Vis Sci (2007) 1.05
Coated microneedles for drug delivery to the eye. Invest Ophthalmol Vis Sci (2007) 1.04
Effect of mitomycin C on the corneal endothelium when used for corneal subepithelial haze prophylaxis following photorefractive keratectomy. J Refract Surg (2007) 1.01
Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin in the ocular histoplasmosis syndrome: one-year results of an uncontrolled, prospective case series. Ophthalmology (2002) 1.00
Influence of dosage form on the intravitreal pharmacokinetics of diclofenac. Invest Ophthalmol Vis Sci (2009) 1.00
Retracted Sclera-choroid-RPE transport of eight β-blockers in human, bovine, porcine, rabbit, and rat models. Invest Ophthalmol Vis Sci (2011) 1.00
Visual outcomes and incidence of recurrent vitreous hemorrhage after vitrectomy in diabetic eyes pretreated with bevacizumab (avastin). Retina (2009) 0.99
Barriers to glaucoma drug delivery. J Glaucoma (2008) 0.99
A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. Invest Ophthalmol Vis Sci (2006) 0.98
Modeling of corneal and retinal pharmacokinetics after periocular drug administration. Invest Ophthalmol Vis Sci (2008) 0.98
Ex vivo confocal microscopy of human LASIK corneas with histologic and ultrastructural correlation. Ophthalmology (2005) 0.98
Interface fluid syndrome in laser in situ keratomileusis after complicated trabeculectomy. J Cataract Refract Surg (2006) 0.96
Drug delivery through the sclera: effects of thickness, hydration, and sustained release systems. Exp Eye Res (2004) 0.95
Expression of JAM-A in the human corneal endothelium and retinal pigment epithelium: localization and evidence for role in barrier function. Invest Ophthalmol Vis Sci (2007) 0.95
Anatomic alterations in aging and age-related diseases of the eye. Invest Ophthalmol Vis Sci (2013) 0.94
In vitro human scleral permeability of fluorescein, dexamethasone-fluorescein, methotrexate-fluorescein and rhodamine 6G and the use of a coated coil as a new drug delivery system. J Ocul Pharmacol Ther (2002) 0.94
Subconjunctival topotecan in fibrin sealant in the treatment of transgenic murine retinoblastoma. Invest Ophthalmol Vis Sci (2008) 0.93
Drug and gene delivery to the back of the eye: from bench to bedside. Invest Ophthalmol Vis Sci (2014) 0.93
Photodynamic therapy with verteporfin in ocular histoplasmosis: uncontrolled, open-label 2-year study. Ophthalmology (2004) 0.93
Particle-stabilized emulsion droplets for gravity-mediated targeting in the posterior segment of the eye. Adv Healthc Mater (2014) 0.92
Suprachoroidal delivery in a rabbit ex vivo eye model: influence of drug properties, regional differences in delivery, and comparison with intravitreal and intracameral routes. Mol Vis (2013) 0.91
Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial. Arch Ophthalmol (2008) 0.89
In vitro sustained human transscleral drug delivery of fluorescein-labeled dexamethasone and methotrexate with fibrin sealant. Curr Eye Res (2005) 0.89
Mucoadhesive microdiscs engineered for ophthalmic drug delivery: effect of particle geometry and formulation on preocular residence time. Invest Ophthalmol Vis Sci (2008) 0.88
Histologic and ultrastructural findings in human corneas after successful laser in situ keratomileusis. Arch Ophthalmol (2002) 0.87
Aging changes of mouse corneal endothelium and Descemet's membrane. Exp Eye Res (2006) 0.87
Effects of enzymatic sterilization detergents on the corneal endothelium. Arch Ophthalmol (2002) 0.86
Recommended practices for cleaning and sterilizing intraocular surgical instruments. J Cataract Refract Surg (2007) 0.85
Outbreak of toxic anterior segment syndrome following cataract surgery associated with impurities in autoclave steam moisture. Infect Control Hosp Epidemiol (2006) 0.85
Pharmacokinetics of intraocular drug delivery of Oregon green 488-labeled triamcinolone by subtenon injection using ocular fluorophotometry in rabbit eyes. Invest Ophthalmol Vis Sci (2008) 0.84
Histopathological analysis of post-laser-assisted in situ keratomileusis corneal ectasia with intrastromal corneal ring segments. Arch Ophthalmol (2005) 0.83
The influence of intraocular pressure on the transscleral diffusion of high-molecular-weight compounds. Invest Ophthalmol Vis Sci (2005) 0.83
Proposed new classification scheme for chemical injury to the human eye. Regul Toxicol Pharmacol (2006) 0.82
Viscoelastic protection from endothelial damage by air bubbles. J Cataract Refract Surg (2002) 0.82
Influence of choroidal neovascularization and biodegradable polymeric particle size on transscleral sustained delivery of triamcinolone acetonide. Int J Pharm (2012) 0.81
Scleral permeability of a small, single-stranded oligonucleotide. J Ocul Pharmacol Ther (2004) 0.81
In vivo ocular fluorophotometry: delivery of fluoresceinated dextrans via transscleral diffusion in rabbits. Invest Ophthalmol Vis Sci (2011) 0.81
Human scleral diffusion of anticancer drugs from solution and nanoparticle formulation. Pharm Res (2009) 0.81
Measurement and prediction of lateral diffusion within human sclera. Invest Ophthalmol Vis Sci (2006) 0.80
Clinical characteristics of hydroxychloroquine retinopathy. Br J Ophthalmol (2010) 0.80
Incidence of postvitrectomy macular edema using optical coherence tomography. Ophthalmology (2009) 0.80
Corneal epithelial testing strategies for safety evaluation of ophthalmic formulations. Cutan Ocul Toxicol (2007) 0.80
Chronic pain after Intacs implantation. J Cataract Refract Surg (2006) 0.79
Correlation between epithelial ingrowth and basement membrane remodeling in human corneas after laser-assisted in situ keratomileusis. Arch Ophthalmol (2010) 0.79
The disposition and bioavailability of 35S-GSH from 35S-GSSG in BSS PLUS in rabbit ocular tissues. J Ocul Pharmacol Ther (2004) 0.79
Transscleral permeability of fluorescent-labeled antibiotics. J Ocul Pharmacol Ther (2005) 0.79
Ophthalmic and systemic findings in interstitial deletions of chromosome 14q: a case feport and literature review. Ophthalmic Genet (2012) 0.79
Keratan sulfate and chondroitin/dermatan sulfate in maximally recovered hypocellular stromal interface scars of postmortem human LASIK corneas. Invest Ophthalmol Vis Sci (2006) 0.78
Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. J Control Release (2003) 0.78
Verteporfin therapy for CNV secondary to OHS. Ophthalmology (2006) 0.78
Retinoblastoma in a 48-year-old woman. Retin Cases Brief Rep (2011) 0.78